Effect of Vitamin D 3 on chemokine levels and regulatory T-cells in pulmonary tuberculosis

International Immunopharmacology

Volumn 34, Issue , 2016, Pages 86-91

  Harishankar, M ^a   Anbalagan, S ^a   Selvaraj, P ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

Author keywords

1,25 Dihydroxyvitamin D 3; Chemokines; Culture filtrate antigen and tuberculosis; Regulatory T cells

Indexed keywords

CHEMOKINE; COLECALCIFEROL; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; BACTERIAL PROTEIN; CCL2 PROTEIN, HUMAN; CFP-10 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; CXCL10 PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL CULTURE; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; STIMULATION; SUPERNATANT; T LYMPHOCYTE SUBPOPULATION; UPREGULATION; CELL CULTURE; DRUG EFFECT; FEMALE; IMMUNOLOGY; MALE; METABOLISM;

ADULT; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINE CCL4; CHEMOKINE CXCL10; CHOLECALCIFEROL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MALE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TUBERCULOSIS, PULMONARY;

EID: 84959441410     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2016.02.021     Document Type: Article

References (30)

1. World Health Organization (WHO) Global Tuberculosis Report 2014
2. A.K. Coussens, R.J. Wilkinson, Y. Hanifa, V. Nikolayevskyy, P.T. Elkington, K. Islam, and et al. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment Proc. Natl. Acad. Sci. U. S. A. 109 2012 15449 15454
3. F. Baeke, T. Takiishi, H. Korf, C. Gysemans, and C. Mathieu Vitamin D: modulator of the immune system Curr. Opin. Pharmacol. 10 2010 482 496
4. M. Vidyarani, P. Selvaraj, M.S. Jawahar, and P.R. Narayanan 1,25 dihydroxyvitamin D3 modulated cytokine response in pulmonary tuberculosis Cytokine 40 2007 128 134
5. P. Selvaraj, M. Harishankar, B. Singh, V.V. Banurekha, and M.S. Jawahar Effect of vitamin D3 on chemokine expression in pulmonary tuberculosis Cytokine 60 2012 212 219
6. A. Coussens, P.M. Timms, B.J. Boucher, T.R. Venton, A.T. Ashcroft, K.H. Skolimowska, and et al. 1Alpha,25-dihydroxyvitamin D3 inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection Immunology 127 2009 539 548
7. A.L. Khoo, L.Y. Chai, H.J. Koenen, M. Oosting, A. Steinmeyer, U. Zuegel, and et al. VitaminD(3) down-regulates proinflammatory cytokine response to Mycobacterium tuberculosis through pattern recognition receptors while inducing protective cathelicidin production Cytokine 55 2011 294 300
8. + regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease Clin. Immunol. 123 2007 50 59
9. J.P. Scott-Browne, S. Shafiani, G. Tucker-Heard, K. Ishida-Tsubota, J.D. Fontenot, A.Y. Rudensky, and et al. Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis J. Exp. Med. 204 2007 2159 2169
10. R. Ribeiro-Rodrigues, T. Resende Co, R. Rojas, Z. Toossi, R. Dietze, W.H. Boom, and et al. A role for CD4 + CD25 + T cells in regulation of the immune response during human tuberculosis Clin. Exp. Immunol. 144 2006 25 34
11. V. Guyot-Revol, J.A. Innes, S. Hackforth, T. Hinks, and A. Lalvani Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis Am. J. Respir. Crit. Care Med. 173 2006 803 810
12. L.E. Jeffery, F. Burke, M. Mura, Y. Zheng, O.S. Qureshi, M. Hewison, and et al. 1,25-Dihydroxyvitamin D(3) and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3 J. Immunol. 183 2009 5458 5467
13. G. Bock, B. Prietl, J.K. Mader, E. Höller, M. Wolf, S. Pilz, and et al. The effect of vitamin D supplementation on peripheral regulatory T cells and β cell function in healthy humans: a randomized controlled trial Diabetes Metab. Res. Rev. 27 2011 942 945
14. B. Prietl, S. Pilz, M. Wolf, A. Tomaschitz, B. Obermayer-Pietsch, W. Graninger, and et al. Vitamin D supplementation and regulatory T cells in apparently healthy subjects: vitamin D treatment for autoimmune diseases? Isr. Med. Assoc. J. 12 2010 136 139
15. G. Chandra, P. Selvaraj, M.S. Jawahar, V.V. Banurekha, and P.R. Narayanan Effect of vitamin D3 on phagocytic potential of macrophages with live Mycobacterium tuberculosis and lymphoproliferative response in pulmonary tuberculosis J. Clin. Immunol. 24 2004 249 257
16. M. Harishankar, K. Afsal, V.V. Banurekha, N. Meenakshi, and P. Selvaraj 1,25-Dihydroxy vitamin D3 downregulates pro-inflammatory cytokine response in pulmonary tuberculosis Int. Immunopharmacol. 23 2014 148 152
17. Y. Song, J. Hong, D. Liu, Q. Lin, and G. Lai 1,25-Dihydroxyvitamin D3 inhibits nuclear factor kappa B activation by stabilizing inhibitor IkappaBalpha via mRNA stability and reduced phosphorylation in passively sensitized human airway smooth muscle cells Scand. J. Immunol. 77 2013 109 116
18. N.P. Kumar, V. Gopinath, R. Sridhar, L.E. Hanna, V.V. Banurekha, M.S. Jawahar, and et al. IL-10 dependent suppression of type 1, type 2 and type 17 cytokines in active pulmonary tuberculosis PLoS One 8 2013 e59572
19. L. Gazzola, C. Tincati, A. Gori, M. Saresella, I. Marventano, and F. Zanini FoxP3 mRNA expression in regulatory T cells from patients with tuberculosis Am. J. Respir. Crit. Care Med. 174 2006 356
20. J. Correale, M.C. Ysrraelit, and M.I. Gaitan Immunomodulatory effects of Vitamin D in multiple sclerosis Brain 132 2009 1146 1160
21. S.W. Kang, S.H. Kim, N. Lee, W.W. Lee, K.A. Hwang, M.S. Shin, and et al. 1,25-Dihyroxyvitamin D3 promotes FOXP3 expression via binding to vitamin D response elements in its conserved noncoding sequence region J. Immunol. 188 2012 5276 5282
22. G.C. Furtado, M.A. Curotto de Lafaille, N. Kutchukhidze, and J.J. Lafaille Interleukin 2 signaling is required for CD4 + regulatory T cell function J. Exp. Med. 196 2002 851 857
23. T.S. Davidson, R.J. DiPaolo, J. Andersson, and E.M. Shevach Cutting edge: IL-2 is essential for TGF-b-mediated induction of Foxp3 + T regulatory cells J. Immunol. 178 2007 4022 4026
24. E.S. Chambers, D. Suwannasaen, E.H. Mann, Z. Urry, D.F. Richards, G. Lertmemongkolchai, and et al. 1α,25-Dihydroxyvitamin D3 in combination with transforming growth factor-β increases the frequency of Foxp3 + regulatory T cells through preferential expansion and usage of interleukin-2 Immunology 143 2014 52 60
25. J.H. Gong, M. Zhang, R.L. Modlin, P.S. Linsley, D. Iyer, Y. Lin, and et al. Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression Infect. Immun. 64 1996 913 918
26. P.K. Sharma, P.K. Saha, A. Singh, S.K. Sharma, B. Ghosh, and D.K. Mitra Foxp3 + regulatory T cells suppress effector T cells function at pathologic site in military tuberculosis Am. J. Crit. Care Resp. Med. 179 2009 1061 1070
27. A. Singh, A.B. Dey, A. Mohan, P.K. Sharma, and D.K. Mitra Foxp3 + regulatory T cells among tuberculosis patients: impact on prognosis and restoration of antigen specific IFN-γ producing T cells PLoS One 7 2012 e44728
28. L. Geffner, N. Yokobori, J. Basile, P. Schierloh, L. Balboa, M.M. Romero, and et al. Patients with multidrug resistant tuberculosis display impaired Th1 response and enhanced regulatory T cells levels in response to an outbreak of multidrug resistant Mycobacterium tuberculosis M and Ra strains Infect. Immun. 77 2009 5025 5034
29. M.L. Bourigault, R. Vacher, S. Rose, M.L. Olleros, J.P. Janssens, V.F. Quesniaux, and et al. Tumor necrosis factor neutralization combined with chemotherapy enhances Mycobacterium tuberculosis clearance and reduces lung pathology Am. J. Clin. Exp. Immunol. 2 2013 124 134
30. Z. Hasan, N. Salahuddin, N. Rao, M. Aqeel, F. Mahmood, F. Ali, and et al. Change in serum CXCL10 levels during anti-tuberculosis treatment depends on vitamin D status Int. J. Tuberc. Lung Dis. 18 2014 466 469